On Wednesday, Ingevity NGVT will release its latest earnings report. Decipher the announcement with Benzinga's help.
Earnings and Revenue
Sell-side analysts expect Ingevity's EPS to be near $1.41 on sales of $365.40 million.
Ingevity EPS in the same period a year ago totaled $1.16. Revenue was $311.20 million. If the company were to match the consensus estimate when it reports Wednesday, EPS would be up 21.55%. Sales would be up 17.42% on a year-over-year basis. Here's how the company's EPS has stacked up against analyst estimates in the past:
Quarter | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 |
EPS Estimate | 1.330 | 0.970 | 0.77 | 1.04 |
EPS Actual | 1.360 | 0.990 | 1.07 | 1.16 |
Stock Performance
Over the last 52-week period, shares are down 4.2%. Given that these returns are generally negative, long-term shareholders are probably upset going into this earnings release.
Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. Analysts have been rating Ingevity stock as Neutral. The strength of this rating has maintained conviction over the past three months.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.